Author:
Sen Saikat,Chakraborty Raja,De Biplab
Reference33 articles.
1. Anonymous. Anakinra improves glycaemia in type 2 diabetes. BMJ. 2007;334: 822.
2. Anonymous. DIAPREV-IT study of diabetes therapy Diamyd® receives further funding and will continue despite disappointing Phase III trial results. Immunotherapy. 2011;3:923–4.
3. Anonymous. Evotec announces update on DiaPep277®. 2014. Accessed from: http://www.evotec.com/article/en/Press-releases/Evotec-announces-update-on-DiaPep277/2653 .
4. Apple J. Diapep277: slowing the progression of type 1 diabetes. 2012. Accessed on: http://asweetlife.org/feature/diapep277-slowing-the-progression-of-type-1-diabetes/ .
5. Bertolaso M, Olsson J, Picardi A, Rakela J. Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations. Diabetes Metab Res Rev. 2010;26:520–4.